Immunofluorescence Assays

Global Market Trajectory & Analytics

MCP12534

EXECUTIVE ENGAGEMENTS

POOL

1741
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

313
Interactions with Platform & by Email

PARTICIPANTS

72
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

213

PAGES

285

EDITION

9

PRICE

USD 5450

CODE

MCP12534


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abcam PLC

Bio-Rad Laboratories, Inc.

Cell Signaling Technology, Inc.

Danaher Corporation

Inova Diagnostics, Inc.

Medipan GmbH

MilliporeSigma

PerkinElmer, Inc.

Sino Biological, Inc.

Thermo Fisher Scientific, Inc.

*Login to Participate & View Data Stacks
View 42 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Immunofluorescence Assays estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 3% CAGR for the next 7-year period.
The Immunofluorescence Assays market in the U.S. is estimated at US$481 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$390.3 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
In the global Antibodies segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$149 Million in the year 2020 will reach a projected size of US$193.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$252.7 Million by the year 2027.

SELECT PLAYERS

Abcam PLC; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; INOVA Diagnostics, Inc.; Medipan GmbH; MilliporeSigma; PerkinElmer, Inc.; Sino Biological Inc.; Thermo Fisher Scientific, Inc.; Vector Laboratories, Inc.

SEGMENTS

» Disease (Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Other Diseases) » End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Contract Research Organizations) » Product (Reagents, Instruments, Antibodies, Kits, Consumables & Accessories) » Type (Indirect Immunofluorescence, Direct Immunofluorescence)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Immunofluorescence Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Immunofluorescence Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunofluorescence Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Indirect Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Indirect Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Indirect Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Direct Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Direct Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Direct Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
China Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
China Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
China Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Immunofluorescence Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Immunofluorescence Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Immunofluorescence Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
France Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
France Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
France Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Immunofluorescence Assays by Product - Reagents, Instruments, Antibodies, Kits and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Immunofluorescence Assays by Product - Percentage Breakdown of Value Sales for Reagents, Instruments, Antibodies, Kits and Consumables & Accessories for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Immunofluorescence Assays by Type - Indirect Immunofluorescence and Direct Immunofluorescence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Immunofluorescence Assays by Type - Percentage Breakdown of Value Sales for Indirect Immunofluorescence and Direct Immunofluorescence for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Immunofluorescence Assays by Disease - Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Immunofluorescence Assays by Disease - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases and Other Diseases for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Immunofluorescence Assays by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Immunofluorescence Assays by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations for the Years 2012, 2020 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com